MS
Mizuho Securities Portfolio holdings
AUM
$27.7M
This Quarter Return
-28.4%
1 Year Return
+23.85%
3 Year Return
+192.43%
5 Year Return
+10.18%
10 Year Return
–
AUM
$344M
AUM Growth
+$344M
(-34%)
Cap. Flow
-$23.7M
Cap. Flow
% of AUM
-6.89%
Top 10 Holdings %
Top 10 Hldgs %
90.95%
Holding
216
New
10
Increased
66
Reduced
86
Closed
22
Top Buys
| 1 |
Sea Limited
SE
|
$4.27M |
| 2 |
Tesla
TSLA
|
$3.01M |
| 3 |
NVIDIA
NVDA
|
$2.64M |
| 4 |
Intuitive Surgical
ISRG
|
$1.69M |
| 5 |
Procter & Gamble
PG
|
$1.63M |
Top Sells
| 1 |
C4 Therapeutics
CCCC
|
$6.41M |
| 2 |
XYZ
Block, Inc.
XYZ
|
$3.89M |
| 3 |
Palo Alto Networks
PANW
|
$3.82M |
| 4 |
Micron Technology
MU
|
$3.22M |
| 5 |
Netflix
NFLX
|
$2.39M |
Sector Composition
| 1 | Consumer Discretionary | 87.84% |
| 2 | Technology | 6.09% |
| 3 | Financials | 1.75% |
| 4 | Communication Services | 1.54% |
| 5 | Healthcare | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
3D Systems Corporation
DDD
$276M
| $8K | ﹤0.01% |
300
-1,310
| -81% | -$34.9K |
|
102
Danaher
DHR
$145B
| $8K | ﹤0.01% |
28
+1
| +4% | +$286 |
|
103
Domino's
DPZ
$15.8B
| $8K | ﹤0.01% |
17
| – | – |
|
104
Gilead Sciences
GILD
$140B
| $8K | ﹤0.01% |
108
+9
| +9% | +$667 |
|
105
HCA Healthcare
HCA
$94.9B
| $8K | ﹤0.01% |
32
+1
| +3% | +$250 |
|
106
Illumina
ILMN
$15.3B
| $8K | ﹤0.01% |
21
-651
| -97% | -$248K |
|
107
Intuit
INTU
$184B
| $8K | ﹤0.01% |
15
| – | – |
|
108
lululemon athletica
LULU
$23.8B
| $8K | ﹤0.01% |
20
-40
| -67% | -$16K |
|
109
Moderna
MRNA
$9.25B
| $8K | ﹤0.01% |
20
-23
| -53% | -$9.2K |
|
110
PepsiCo
PEP
$207B
| $8K | ﹤0.01% |
54
-2
| -4% | -$296 |
|
111
RTX Corp
RTX
$212B
| $8K | ﹤0.01% |
97
+20
| +26% | +$1.65K |
|
112
Snowflake
SNOW
$77.4B
| $8K | ﹤0.01% |
26
| – | – |
|
113
Target
TGT
$41.9B
| $8K | ﹤0.01% |
34
| – | – |
|
114
Travelers Companies
TRV
$61B
| $8K | ﹤0.01% |
50
-18
| -26% | -$2.88K |
|
115
Zoetis
ZTS
$67.6B
| $8K | ﹤0.01% |
39
+1
| +3% | +$205 |
|
116
American Express
AXP
$229B
| $7K | ﹤0.01% |
39
| – | – |
|
117
Boston Scientific
BSX
$158B
| $7K | ﹤0.01% |
154
-1
| -0.6% | -$45 |
|
118
CVS Health
CVS
$93.6B
| $7K | ﹤0.01% |
82
+1
| +1% | +$85 |
|
119
Chevron
CVX
$325B
| $7K | ﹤0.01% |
74
-1,799
| -96% | -$170K |
|
120
DocuSign
DOCU
$14.9B
| $7K | ﹤0.01% |
28
| – | – |
|
121
L3Harris
LHX
$51.5B
| $7K | ﹤0.01% |
30
-1
| -3% | -$233 |
|
122
Northrop Grumman
NOC
$84.1B
| $7K | ﹤0.01% |
20
| – | – |
|
123
Snap
SNAP
$12.1B
| $7K | ﹤0.01% |
101
+2
| +2% | +$139 |
|
124
Texas Instruments
TXN
$180B
| $7K | ﹤0.01% |
37
| – | – |
|
125
Unity
U
$16.6B
| $7K | ﹤0.01% |
56
+4
| +8% | +$500 |
|